Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clenbuterol for Skeletal Muscle Glucose Uptake
NCT03800290Phase 2Completed
- Sponsor
- Maastricht University
- Start
- Jun 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clenbuterol in type 2 diabetes mellitus (T2DM), sponsored by Maastricht University. Primary endpoint: Insulin-stimulated peripheral glucose disposal at 2 weeks. Started Jun 2019; status: completed.
02
Drugs
clenbuterol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03800290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03800290.